NAUT
NAUT
NASDAQ · Life Sciences Tools & Services

Nautilus Biotechnology Inc

Penny Stocks Healthcare Stocks
$2.03
+0.01 (+0.50%)
As of Feb 8, 2:01 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +1,208.4% upside
Low Target $24.26
Average Target $26.56
High Target $41.87
Current Price $2.03
Current
$2.03
Target
$26.56
$24.26 $26.56 avg $41.87
Scenario Analysis
Bear Case
$24.26
1,095.1%
Low target
Base Case
$26.56
+1,208.4%
Avg target
Bull Case
$41.87
+1,962.6%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$29.04
-93.0% from high
52-Week Low
$16.15
+-87.4% from low
Target vs 52W High
$26.56
-8.5% vs high
Next Earnings Report
Feb 26, 2026 · After Market Close
9d
until earnings
EPS Est: $-0.14
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
 Strong Buy 33 82% $369.21 -32.0%
DHR
Danaher Corp
 Strong Buy 31 87% $158.11 -27.0%
A
Agilent Technologies Inc
 Buy 29 72% $64.69 -50.1%
IQV
Iqvia Holdings Inc
 Strong Buy 30 80% $82.96 -55.8%
MTD
Mettler-Toledo International
 Hold 21 43% $170.43 -87.6%
WAT
Waters Corp
 Buy 25 56% $189.60 -50.3%
ILMN
Illumina Inc
 Hold 26 50% $169.36 +41.5%
WST
West Pharmaceutical Services
 Strong Buy 23 78% $136.24 -45.3%